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Testicular damage is a serious complication of diabetes mellitus 
resulting in male infertility, which is associated with caspase-3 and IGF-1 
mRNA expression. Platelet-rich plasma (PRP), with its rich growth factor 
composition, has proven beneficial in regenerative therapy. It is believed 
that PRP has not been studied in testes for complication of diabetes mellitus 
and there are no studies in the literature concerning the influence of PRP on 
expressions of growth factors in diabetic rat testis. The aim of this study was 
to investigate the efficacy of adjunctive PRP in insulin treatment for repair 
of testicular damage in a diabetic rat model. Diabetes was induced by 
administering single dose 60mg/kg streptozotocin. Twenty Wistar male rats 
were divided into four groups: group 1, control group; group 2, diabetes 
without treatment; group 3, diabetes with treated insulin; and group 4, 
diabetes with treated insulin and PRP. Rats were euthanized after two weeks 
of treatment, and testes were taken for caspase-3 and IGF-1 mRNA 
expression measurements. Diabetes mellitus induction caused a significant 
increase in caspase-3 mRNA expression with p=0.049 and significant 
decrease in IGF-1 mRNA expression with p=0.004. There was no difference 
in caspase-3 and IGF-1 mRNA expression of the diabetic rat testis given 
insulin and PRP compared to without PRP.  




Male reproductive system damage due to 
diabetes mellitus (DM) is a disorder that results in 
a decrease in male fertility (Kianifard et al., 2012; 
Shi et al., 2017; Sisman et al., 2014). Testicular 
damage due to DM is damage that occurs other 
than the pancreas (Sisman et al., 2014). A 
molecular mechanism in the form of oxidative 
stress and apoptosis causes testicular damage            
(Shi et al., 2017). Information about the 
mechanism of damage caused by DM through 
oxidative stress and apoptosis is the reason for 
further research, namely study on substances that 
can prevent oxidative stress and apoptosis and aid 
in repairing  
testicular damage due to DM. The increase in 
caspase-3 is a link between oxidative stress                  
and apoptosis. The increase in caspase-3 in the 
testes becomes a measure of testicular damage and 
a decrease in caspase-3 is an indicator of the 
success of therapy (Morsy et al., 2014; Shi et al., 
2017). 
 
Research related to growth factors in DM 
testicles via streptozotocin (STZ) induction              
shows a decrease in vascular endothelial growth 
factor (VEGF) (Sisman et al., 2014) and insulin          
like growth factor-I (IGF-1) (Olchosky et al., 1991). 
IGF-1 deficiency in the testis can damage the testes 
so that they cannot function (Castilla-Cortázar                 
et al.,   2015;  Puche   and   Castilla-Cortázar, 2012).  
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Provision of Platelet-Rich Plasma (PRP) causes an 
increase in IGF-1. Increased IGF-1 after 
administration of PRP was found in rat tendons 
and human serum (Lyras et al., 2010; Wasterlain et 
al., 2013). IGF-1 was found to be higher in PRP 
compared with IGF-1 in whole blood. IGF-1 found 
in PRP has a major role in tissue repair (Dhillon et 
al., 2012). The role of IGF-1 can overcome 
testicular damage, based on the improvement of 
testicular damage after administration of IGF-1 
(Castilla-Cortázar et al., 2015). Research using IGF-
1 in testicular cells concluded that IGF-1 can 
prevent apoptosis in germinal cells (Ozkurkcugil et 
al., 2004) and Leydig cells (Wang and Hardy, 2004; 
Yoon and Roser, 2010). This study aimed to 
investigate the efficacy of adjunctive PRP in insulin 
treatment for repair of testicular damage in a 
diabetic rat model by assessing caspase-3 and IGF-
1 mRNA expression. 
 
MATERIAL AND METHODS 
The study was approved by the Medical              
and Health Research Ethics Committee of FK-KMK 
UGM, Yogyakarta, Indonesia (Permission number: 
KE/FK/1056/EC/2018). Twenty Wistar male rats 
(Rattus norvegicus) were obtained from the 
Department of Pharmacology and Therapy FK-
KMK UGM (Yogyakarta, Indonesia). The rats              
were 8 weeks old and their mean weight was 
210±60g. The rats were maintained in spacious 
cages and were given food and water ad libitum. 
The animal room was ventilated and was under a 
12h/12h light-dark schedule.  
Four study groups were formed randomly: 
Group 1: The control group (Control): Rats that 
received single i.p injections an equal volume of 
NaCL 0.9%; Group 2:  The diabetes without 
treatment group (DM-0): Rats that received a 
single i.p injection of STZ in a dose of 60mg/kg BW   
for induction of diabetes. After 72h (considered 
day 0) of STZ injection, blood samples were 
collected from the retroorbital vein and glucose 
levels were measured. Individual glucose levels 
that reached above 300mg/dL were considered 
diabetic; Group 3: The diabetes with insulin group 
(DM+I): Rats that received a single i.p injection of 
STZ in a dose same time and dose as the DM-0 
group; after 3 weeks 3 days with confirmation of 
the induction of the diabetes, rats received Lantus® 
(insulin glargine) in a dose of 0.9 Unit/100mg  BW 
by subcutaneous (SC) injection every day for 2 
weeks; Group 4: The diabetes with PRP and insulin 
group (DM+I-PRP): Rats that received a single i.p 
injection of STZ in a dose same time  and  dose as 
the DM-0 group; Rats received a subcutaneous (SC) 
injection of Lantus® (insulin glargine) in the           
same time and dose as the DM+I group. Rats 
received PRP in a dose of 0.1mL (Platelet 
>1.000.000/µL) by subscrotal injection three times 
for 2 weeks. 
 
Preparation of Platelet-rich plasma 
For the preparation of PRP, 10mL of fresh 
venous blood with 1.4mL citrate buffer 
(anticoagulant) were collected into a single syringe 
from an antebrachial vein under aseptic 
conditions. The blood was subjected to double 
centrifugation methods (Prosys PRP, Prodizen 
Inc), and in the first centrifugation the tubes were 
centrifuged at 1200 revolutions per minute (rpm) 
for 10min. This resulted in 3 different density 
compartments; the inferior layer containing red 
blood cells, the intermediate layer containing buffy 
coat of white blood cells, and the superior layer 
containing plasma. The plasma containing platelets 
was protected from red blood cells by being 
connected to empty syringes. An empty syringe in 
the side position was set with the connector above 
the syringe containing plasma in a vertical position. 
The plasma was centrifuged again at 3500rpm for 
10min. This procedure resulted in the production 
of platelet-rich plasma (PRP). Platelets were 
counted using an automated hematology analyzer 
(Sysmex KX 21, Yuesen Med). Platelet counts 
>1.000.000/µL were used. 
 
Euthanasia 
After final weight measurements and blood 
samples were collected for glucose measurements 
(by GOD PAP kit), the rats were euthanized (by 
decapitation). After testis sample collection for 
analysis, the rats were cremated through 
incineration in an appropriate environment. 
 
Total RNA extraction and cDNA synthesis 
The total RNA from the testicular tissue was 
isolated using the TRI-RNA reagents (Favorgen, 
Taiwan). The concentrations of RNA were 
determined by NanoVue Plus spectrophotometer 
(GE Healthcare, USA). Total RNA was extracted 
from testes of the rats.  
The integrity of RNA samples was verified 
by measuring the ratio of ODs at 260nm and 
280nm. Only the RNA samples that had a ratio >1.8 
were used for the subsequent cDNA synthesis. The 
first-strand cDNA was synthesized from RNA using  
cDNA synthesis kit (Smobio, Taiwan) according to 
manufacturer’s instructions. 
Effect of Platelet-rich Plasma on Caspase-3 and IGF-1 mRNA 
100   Volume 30 Issue 2 (2019) 
Reverse Transcriptase-Polymerase Chain 
Reaction (RT-PCR) 
The reverse transcriptase polymerase chain 
reactions (PCR) for caspase-3, IGF-1 and β-actin 
were performed using Thermal Cycler system 
(Select BioProduct, Taiwan), with the following 
primer pairs: caspase-3 forward : 5’-CGT ACA GGT 
TCA GCA TGG C-3’, and reverse : 5’-CCG ACT TCC 
TGT ATG CTT ACT C-3’ ;IGF-1 forward 5’-CGT ACC 
AAA ATG AGC GCA CC-3,  and reverse 5’-TCC GGA 
ACG AAC ACT CAT CC-3; β-actin 1 forward: 5’-ACA 
ACC TTC TTG CAG CTC CTC-3’,  and reverse 5’-AAT 
GCC GTG TTC AAT GGG GT-3’. Each Thermal Cycler 
PCR run consisted of 35 cycles with initial 
denaturation time of 2 min at 94ᵒC. The cycling for 
all primers was set at: 94ᵒC for 10 s, 60ᵒC for 20 s, 
72ᵒC for 48s. The last extension time was at 10min 
at 72ᵒC. Agarose gel electrophoresis was used to 
confirm the specificity of the priming. RT-PCR 
products were visualized with UV light and 
quantified by densitometry analysis from ImageJ 
software. Caspase-3 and IGF-1 were expressed 
relative to that of β-actin in the same samples. 
 
Statistical analysis 
Data presented in this paper are reported 
mean ± standard deviation (SD). One-way analysis 
of variance (ANOVA) followed by LSD’s multiple 
comparison test was performed for analyzing 
differences between treatment group. Statistical 
significance was considered for p<0.05. 
 
RESULTS AND DISCUSSION 
Animal model-body weight and serum glucose  
Weight loss in the DM group compared to 
control group was significantly different (Table I). 
Weight loss is in line with the state of 
hyperglycemia experienced, relevant to research 
conducted by Gandhi et al., (2006). Giving insulin 
caused an increase in body weight compared to DM 
group without insulin.  The  cause of weight gain is  
because insulin has an anabolic effect on proteins 
(Dimitriadis et al., 2011). Wolfe (2000) states that 
protein synthesis is stimulated by insulin. Carver 
(2006) also explained that the effect of insulin on 
weight gain was due to the anabolic effect of 
protein in the muscles and lipogenesis. The insulin-
induced lipogenesis is caused by the transcription 
of the sterol regulatory element binding protein-1 
(SREBP-1), which will cause lipogenic gene 
expression (Kersten, 2001).  
The high blood glucose levels in the DM 
group who were given combined insulin and PRP 
therapy compared with the DM group given insulin 
without PRP, was due to the presence of glucose 
levels in PRP. It was found that there is the 
presence of glucose levels other than leukocytes. 
The mean and SD of the glucose           levels were 
18.5±2.73 - 23.6±1.36mmol/L in the Fitzpatrick et 
al. (2017) study. The results of this glucose level 
were obtained using 4 different kits. 
 
Caspase-3 mRNA expression in testicular rats 
Caspase-3 mRNA expression in the DM 
group was higher than the control group but the 
significant value of 0.049 while very close to 0.05 
was not significant (Figure 1), which indicates an 
additional need for STZ induction time. This study 
used 3 weeks 3 days from DM or 4 weeks for STZ 
induction, then added 2 weeks for insulin and PRP 
administration. The use of STZ induction time 
refers to a study conducted by Olchosky et al. 
(1991), which examined IGF-1 levels of 17-20 days 
(3 weeks) in DM rats. Whereas in other studies 
such as Sisman et al. (2014), it took 5 weeks after 
STZ administration to examine VEGF in the testes. 
On the other hand, Kianifard et al. (2012) needed 
10 weeks to study damage of mitochondrial Sertoli 
cells and Leydig cells in DM testes. Kong et al. 
(2016) used a time of 2 months (8 weeks) during 
the STZ induction period to see the effect of 
therapy on testicular repair. 
  
Table I. The mean and standard deviation of rats’ weight and blood glucose levels after 2 weeks of insulin 
and PRP administration. The significant difference between the two groups was determined by ANOVA 
followed by LSD post hoc. 
 
 Control DM-0 DM+I DM+I-PRP 
Last weight (g) 339.80±13.51 (5) 173.80±19.91***(5) 212.00±16.73***#(5) 199.20±30.17 *** (5) 
Blood glucose 
level (mg/dL) 
85.08±10.08 (5) 472.62±14.53 ***(5) 437.70±7.78 *** (5) 483.16±47.24 ***+(5) 
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 Increased caspase-3 mRNA expression in 
the control group was because physiological 
apoptosis occurs in the process of spermato-
genesis (Said, 2004). The presence of caspase-3             
in the control group was also in line with the  study 
of Sekerci et al. (2017), that involved giving PRP in 
the testis which experienced torsion. Morsy et al. 
(2014) also found the same result, finding the 
higher presence of caspase-3 expression in the 
control group compared to the DM group. 
The high caspase-3 mRNA expression in the 
control group and DM group without insulin 
compared to the insulin therapy groups, both with 
PRP and without PRP, showed that the addition of 
insulin can reduce caspase-3 in the testis. Insulin 
activates phosphoinositol 3 kinase (PI3K) which is 
anti-apoptotic and thus decreases apoptosis lower 
than those not given insulin, according to the result 
obtained through in vitro research (Kang et al., 
2003).   A    longer   study   time  is  needed   so   that  
  
 
Figure 1.Caspase-3 / β-actin mRNA expression in rat testes after 2 weeks of insulin and PRP administration. 
(A) Representative figure of RT-PCR for caspase-3 and β-actin. (B) Densitometry analysis for caspase-3 
mRNA expression in rat testes, measured as densitometry reading of PCR products normalized with 
housekeeping gene (β-actin). Results are expressed as mean ±SD. Significance is indicated by * for  p<0.05 




Figure 2. IGF-1 / β-actin mRNA expression in rat testes after 2 weeks of insulin and PRP administration. (A) 
Representative figure of RT-PCR for IGF-1 and β-actin. (B) Densitometry analysis for IGF-1 mRNA 
expression in rat testes, measured as densitometry reading of PCR products normalized with housekeeping 
gene (β-actin). Results are expressed as mean ± SD. Significance is indicated by * for p < 0.05 and ** for p < 
0.01 compared to Control. 
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caspase-3 derived is caspase-3. A longer time is 
also required for STZ induction to ensure a 
decrease in caspase-3 mRNA expression from 
pathological apoptosis due to DM. 
Caspase-3 mRNA expression on insulin 
administration without PRP was lower than the 
administration of insulin combined with PRP, but 
this difference was not significant. The cause of 
higher caspase-3 in the DM+I-PRP group than in 
the DM+I group was because of the presence of 
leukocytes contained in PRP. Pavlovic et al. (2016) 
stated that the presence of leukocytes can trigger 
ROS. However, Wu et al. (2016) stated that 
leukocytes can influence the therapy of PRP 
administration if the leukocyte level in PRP reaches 
more than 21,000/mL. Devereaux et al.  (2018) 
states that the presence of leukocytes does not 
affect the success of PRP therapy. The existence of 
this controversy requires additional research to 
determine the safety of the use of PRP if 
accompanied by leukocytes (Martínez-Zapata et al., 
2009). 
 
IGF-1 mRNA expression in testicular rats 
This study obtained IGF-1 mRNA expression 
in the testis for all DM groups significantly lower 
than the control group (Figure 2). The group given 
insulin had an increase in IGF-1 mRNA expression 
compared with the DM group without insulin 
therapy, but it was not significant. Addition of PRP 
to the testis with a level of 0.1mL with a frequency 
of 3 times in 2 weeks did not increase IGF-1 mRNA 
expression. This is different from the 
administration of PRP in fractured rats (Lyras et al., 
2010) and in humans who are athletes who need 
recovery (Wasterlain et al., 2013). Lyras et al. 
(2010) conducted a gradual examination to assess 
the increase in IGF-1 in the endotendon, so that it 
could be assessed to increase IGF-1 levels. 
Wasterlain et al. (2013) also did something similar, 
namely when adding the existence of the 
examination stage, it was found that IGF-1 
increased initially but there was no further 
improvement. 
The results of this study indicate that PRP in 
a subscrotal injection does not increase IGF-1 
mRNA expression in the diabetic rat testis. It could 
even be that PRP administration can block the 
production of IGF-1 in the testes because of 
negative feedback in the hypothalamus which 
reduces growth hormone-releasing hormone 
(GHRH) levels, then the reduced GHRH level will 
affect the anterior pituitary to produce GH (Barrett, 
2017). The presence of GH is important in the 
production of IGF-1 (Nambam and Schatz, 2018). 
The presence of GH also determines the success of 
stem cells (Chemaitilly and Sklar, 2007). DM 
conditions will certainly reduce GH due to 
disorders of the hypothalamus (Bonert and 
Melmed, 2017). 
This study indicates that the addition of PRP 
did not affect the improvement compared to 
administration of insulin without PRP. The results 
of the conclusions are the same as Levy et al. 
(2018), who used PRP in patients who had 
problems with the tendon. But the results of this 
study are different from studies using PRP to repair 
damage to the ovaries and testes. Studies by 
Bakacak et al. (2015) and Sekerci et al. (2017) 
revealed that there was improvement in the 
provision of PRP. 
The difference between this research and 
the research that states the success of PRP is the 
way of administering PRP, namely intraperitoneal 
injection in ovarian torsion (Bakacak et al., 2015) 
and intratesticular in testicular torsion (Sekerci et 
al., 2017). The method done by intratesticular 
injection is prone to autoimmune sperm because it 
damages the blood testis barrier. Damage to the 
blood testis barrier will conflict with the goal of 
repairing the testis, namely maintaining male 
fertility (Bronson, 1999; Koksal et al., 2007). 
 
CONCLUSION 
There was no difference in caspase-3 and 
IGF-1 mRNA expression in the diabetic rat testis 
given insulin and PRP compared to without PRP.  
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